The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision.
Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more …

Interest in the relationship between cannabis use and psychosis has increased dramatically
in recent years, in part because of concerns related to the growing availability of cannabis …

Mental disorders have a high prevalence compared with many other health conditions and
are the leading cause of disability worldwide. Several studies performed in the last years …

The therapeutic benefits of the current medications for patients with psychiatric disorders
contrast with a great variety of adverse effects. The endocannabinoid system (ECS) …

Cannabis use leads to symptom exacerbation in schizophrenia patients, and
endocannabinoid ligands have been studied as tentative schizophrenia therapeutics. Here …

Schizophrenia is characterized by marked language deficits, but it is not clear how these
deficits arise from the alteration of genes related to the disease. The goal of this paper is to …

Cannabis-inspired medical products are garnering increasing attention from the scientific
community, general public, and health policy makers. A plethora of scientific literature …

Objective: To test the hypothesis that genetic variations of cannabinoid receptors contribute
to the pathophysiology of cognitive deficits in schizophrenia. Methods: In this genetic …

Language has been argued to arise, both ontogenetically and phylogenetically, from
specific patterns of brain wiring. We argue that it can further be shown that core features of …

Background Gilles de la Tourette syndrome (GTS) is a neuropsychiatric disorder of unknown
etiology, although a major role of genetic factors has been established. Cannabis-based …